March 7, 2018 / 1:06 PM / 6 months ago

BRIEF-Tocagen Receives EMA Orphan Medicinal Product Designation For Toca 511 & Toca FC For Glioma Treatment

March 7 (Reuters) - Tocagen Inc:

* TOCAGEN RECEIVES EUROPEAN MEDICINES AGENCY ORPHAN MEDICINAL PRODUCT DESIGNATION FOR TOCA 511 & TOCA FC FOR THE TREATMENT OF GLIOMA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below